Medicordis SRL
Medicordis reported revenue of 157,510 € for the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
The score of Medicordis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +24 % Equity +4 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medicordis's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 157,510 € | ||||
| Net result | 8,034 € | ||||
| Equity | 181,112 € | ||||
| Cash | 10,464 € | ||||
| EBITDA | 45,220 € | ||||
| Total assets | 263,536 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Medicordis's financial analysis
- Solvency68.7%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medicordis
Medicordis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0861.864.103
- VAT number
- BE0861864103
- Peppol
- Registered · 0208:0861864103 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2003
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Medicordis (SRL) has been based in Uccle since 2003, active in: medical specialists activities. For 2025, it reports revenue of 157,510 €, a net profit of 8,034 € and equity of 181,112 €. Its solvency stands at 68.7%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medicordis
Companies in the same business, of comparable size and area, outside its group.
- Dr Héloïse Bourbier Medical specialists activities Schaerbeek · balance sheet 263,331 €
- Dr. Tijs Bringmans, cardioloog Medical specialists activities Sint-Katelijne-Waver · balance sheet 263,267 €
- BK Urologie Medical specialists activities Ghent · balance sheet 263,871 €
- Cabinet Medical Berghmans Medical specialists activities Namur · balance sheet 263,185 €
- Dr. Anne-Sophie Maryns - Gynaecoloog Medical specialists activities Schelle · balance sheet 263,955 €
- Dr. Annemijn Witdouck, anesthesie Medical specialists activities Hasselt · balance sheet 264,009 €
- Dr BETEK Medical specialists activities Ans · balance sheet 264,045 €
- HTS Clinic Medical specialists activities Etterbeek · balance sheet 264,047 €
Frequently asked questions about Medicordis
What is the revenue of Medicordis?
According to the 2025 annual accounts filed with the NBB, the revenue of Medicordis amounts to 157,510 €.
What is the VAT number of Medicordis?
In Belgium, the VAT number is the company number prefixed with BE: BE0861864103 for Medicordis, if the company is VAT-registered. Its company number (CBE) is 0861.864.103.
Where is the registered office of Medicordis?
According to the CBE register, the registered office of Medicordis is in 1180 Uccle.
What is the equity of Medicordis?
At the close of the 2025 financial year, the equity of Medicordis amounts to 181,112 €, a solvency of 68.7% of total assets.
Who manages Medicordis?
The register lists 1 active mandates at Medicordis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medicordis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →